Delivery of subcutaneous immunoglobulin by rapid “push” infusion for primary immunodeficiency patients in Manitoba: a retrospective review

BACKGROUND: Both intravenous and subcutaneous human immune globin G (IgG) replacement (IVIG and SCIG, respectively) reduce severe infection and increase serum IgG levels in primary immune deficiency disorder (PIDD) patients who require replacement. SCIG can be administered either with the aid of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Graham, Kalicinsky, Chrystyna, Warrington, Richard, Miguel, Marianne, Reyes, Jeannette, Rubin, Tamar S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218483/
https://www.ncbi.nlm.nih.gov/pubmed/32426003
http://dx.doi.org/10.1186/s13223-020-00431-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218483/
https://www.ncbi.nlm.nih.gov/pubmed/32426003
http://dx.doi.org/10.1186/s13223-020-00431-3

Ejemplares similares